Description
GENERAL RADIOPHARMACEUTICALS
First action · last action
2021-02-19 · 2022-08-02
Transactions
2
First transaction's obligation
$1,336,543
Base + all options value (sum of deltas)
$1,929,605
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24221D0057
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-02-19+$1,336,543= $1,336,543
- Mod P000012022-08-02-$743,480= $593,062
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-02-19 | +$1,336,543 | $1,336,543 | GENERAL RADIOPHARMACEUTICALS |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2022-08-02 | −$743,480 | $593,062 | GENERAL RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQAKL78AXMT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0481 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $3,356,110 | FY2026 |
| 36C24426P0225 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $148,383 | FY2026 |
| 36C24226D0037 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24226N0381 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $959,170 | FY2026 |
| 36C24425N0451 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $180,327 | FY2025 |
| 36C24225N0386 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $330,602 | FY2025 |
Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226P0942 | PRIORITY HEALTHCARE DISTRIBUTION INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $15,746 | FY2026 |
| 36C24226P0910 | THERACOM, L.L.C. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $39,143 | FY2026 |
| 36C24226P0901 | COVERMYMEDS PHARMACY LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $16,331 | FY2026 |
| 36C24226P0895 | CARDINAL HEALTH 108, LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $31,219 | FY2026 |
| 36C24226P0900 | COVERMYMEDS PHARMACY LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $11,315 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24221N0440_3600_36C24221D0057_3600 · retrieved 2026-09-26.